Literature DB >> 1379610

Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma.

J Teixidó1, M E Hemler, J S Greenberger, P Anklesaria.   

Abstract

Hematopoietic stem cell interaction with elements of the underlying stroma is essential for sustained normal hematopoiesis. Here we have determined that adhesion receptors in the integrin family play a role in promoting adhesion of human hematopoietic stem cells to cultured human marrow stromal cells. Enriched CD34hi progenitor cells expressed VLA-4, VLA-5, and at least one or more beta 2 integrins. Homogeneous marrow stromal cell monolayers capable of supporting proliferation of cocultivated CD34hi cells expressed VCAM-1 and fibronectin (ligands for VLA-4 and VLA-5) as well as ICAM-1 (ligand for LFA-1 and Mac-1). Adhesion-blocking experiments indicated that VLA-4/VCAM-1, VLA-5/fibronectin, and beta 2-integrin/ICAM-1 pathways all are important for CD34hi cell attachment to stromal cells. Consistent with this suggestion, IL-1 stimulation of stromal cells caused both increased VCAM-1 and ICAM-1 expression and increased attachment by CD34hi bone marrow cells. In addition, CD34hi cells utilized VLA-4 to adhere to purified VCAM-1 and employed VLA-5 (and to a lesser extent VLA-4) to adhere to purified fibronectin. Together these results suggest that CD34hi stem cells may utilize multiple integrin-mediated adhesion pathways to localize within specialized microenvironmental niches created by marrow stromal cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379610      PMCID: PMC443110          DOI: 10.1172/JCI115870

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  76 in total

1.  Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CD3-dependent T cell proliferation.

Authors:  L C Burkly; A Jakubowski; B M Newman; M D Rosa; G Chi-Rosso; R R Lobb
Journal:  Eur J Immunol       Date:  1991-11       Impact factor: 5.532

2.  VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

Authors:  M J Elices; L Osborn; Y Takada; C Crouse; S Luhowskyj; M E Hemler; R R Lobb
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

3.  Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation.

Authors:  M S Diamond; D E Staunton; S D Marlin; T A Springer
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

4.  Identification of distinctive stromal elements in erythroid and neutrophil granuloid spleen colonies: light and electron microscopic study.

Authors:  R W La Pushin; J J Trentin
Journal:  Exp Hematol       Date:  1977-11       Impact factor: 3.084

5.  Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110.

Authors:  A S Freedman; J M Munro; G E Rice; M P Bevilacqua; C Morimoto; B W McIntyre; K Rhynhart; J S Pober; L M Nadler
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

6.  Human B lymphocytes define an alternative mechanism of adhesion to fibronectin. The interaction of the alpha 4 beta 1 integrin with the LHGPEILDVPST sequence of the type III connecting segment is sufficient to promote cell attachment.

Authors:  A Garcia-Pardo; E A Wayner; W G Carter; O C Ferreira
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

7.  Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans.

Authors:  G S Kansas; M J Muirhead; M O Dailey
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

8.  Barrier cells: stromal regulation of hematopoiesis and blood cell release in normal and stressed murine bone marrow.

Authors:  L Weiss; U Geduldig
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

9.  Adhesion of immature thymocytes to thymic stromal cells through fibronectin molecules and its significance for the induction of thymocyte differentiation.

Authors:  K Utsumi; M Sawada; S Narumiya; J Nagamine; T Sakata; S Iwagami; Y Kita; H Teraoka; H Hirano; M Ogata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

10.  Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin.

Authors:  C M Verfaillie; J B McCarthy; P B McGlave
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  61 in total

1.  Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.

Authors:  T Ponomaryov; A Peled; I Petit; R S Taichman; L Habler; J Sandbank; F Arenzana-Seisdedos; A Magerus; A Caruz; N Fujii; A Nagler; M Lahav; M Szyper-Kravitz; D Zipori; T Lapidot
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human Dermis.

Authors:  Alexander M S Barron; Julio C Mantero; Jonathan D Ho; Banafsheh Nazari; Katharine L Horback; Jag Bhawan; Robert Lafyatis; Christina Lam; Jeffrey L Browning
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

3.  Expression of Pitx2 in stromal cells is required for normal hematopoiesis.

Authors:  Aurélie Kieusseian; Jalila Chagraoui; Cécile Kerdudo; Philippe-Emmanuel Mangeot; Philip J Gage; Nicole Navarro; Brigitte Izac; Georges Uzan; Bernard G Forget; Anne Dubart-Kupperschmitt
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

4.  Surface-immobilization of adhesion peptides on substrate for ex vivo expansion of cryopreserved umbilical cord blood CD34+ cells.

Authors:  Xue-Song Jiang; Chou Chai; Yue Zhang; Ren-Xi Zhuo; Hai-Quan Mao; Kam W Leong
Journal:  Biomaterials       Date:  2006-01-10       Impact factor: 12.479

5.  Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization.

Authors:  Melissa van Pel; Ronald van Os; Gerjo A Velders; Henny Hagoort; Peter M H Heegaard; Ivan J D Lindley; Roel Willemze; Willem E Fibbe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

6.  Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion.

Authors:  Peter Vanderslice; Ronald J Biediger; Darren G Woodside; Wells S Brown; Sayadeth Khounlo; Navin D Warier; C William Gundlach; Amy R Caivano; William G Bornmann; David S Maxwell; Bradley W McIntyre; James T Willerson; Richard A F Dixon
Journal:  J Biol Chem       Date:  2013-05-23       Impact factor: 5.157

7.  SP/drug efflux functionality of hematopoietic progenitors is controlled by mesenchymal niche through VLA-4/CD44 axis.

Authors:  J-V Malfuson; L Boutin; D Clay; C Thépenier; C Desterke; F Torossian; B Guerton; A Anginot; T de Revel; J-J Lataillade; M-C Le Bousse-Kerdilès
Journal:  Leukemia       Date:  2013-09-03       Impact factor: 11.528

8.  VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin.

Authors:  J C van der Loo; X Xiao; D McMillin; K Hashino; I Kato; D A Williams
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha.

Authors:  R Bhatia; P B McGlave; C M Verfaillie
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation.

Authors:  R W Hurley; J B McCarthy; C M Verfaillie
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.